Blogs
New from the Proscia blog: Digital pathology has evolved far beyond improving quality and efficiency. It’s becoming a strategic gateway to business growth. This was the central message our CEO David West delivered during his breakout...
As life sciences R&D teams increasingly leverage digital pathology and AI to accelerate their precision medicine programs, Proscia’s Concentriq LS platform is handling unprecedented volumes of high-resolution images, complex annotations,...
New on the Proscia bMaximize your digital investment with pathologist-centered innovation Here at Proscia, we believe the key to achieving productivity and confidence in digital pathology lies in delivering an intelligent and intuitive...
Fortis: The institute will bring together a team of medical experts, including molecular hematology, oncology, neurology, paediatrics, pathology, and genomic scientists along with bioinformaticians and AI engineers Fortis Healthcare launched...
The United States and Canadian Academy of Pathology (USCAP) Annual Meeting is always a standout—a forum for trading the latest insights, engaging with the Concentriq community, and enjoying time with our team. This year’s event was no...
Diagnexia and Stratipath: Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based prognostic risk profiling tool, to healthcare providers...
